Cystoid macular edema secondary to albumin-bound paclitaxel therapy

Archives of Ophthalmology

Volumn 126, Issue 11, 2008, Pages 1605-1606

  Smith, Stacy V ^b   Benz, Matthew S ^b   Brown, David M ^a  

^a Vitreoretinal Consultants   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DOCETAXEL; PACLITAXEL; TRASTUZUMAB;

ADULT; BREAST CANCER; CAPILLARY LEAK SYNDROME; CASE REPORT; CLINICAL FEATURE; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; PATHOGENESIS; PRIORITY JOURNAL; RETINA MACULA CYSTOID EDEMA; SYMPTOM; VISUAL ACUITY;

ALBUMINS; ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; MACULAR EDEMA; MIDDLE AGED; PACLITAXEL; RETINA; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 55949119040     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archopht.126.11.1605     Document Type: Letter

References (4)

1. Teitelbaum BA, Tresley DJ. Cystic maculopathy with normal capillary permeability secondary to docetaxel. Optom Vis Sci. 2003;80(4):277-279.
2. Telander DG, Sarraf D. Cystoid macular edema with docetaxel chemotherapy and the fluid retention syndrome. Semin Ophthalmol. 2007;22(3):151-153.
3. Joshi MM, Garretson BR. Paclitaxel maculopathy. Arch Ophthalmol. 2007;125(5):709-710.
4. Gradishar WJ, Tjulandin S, Davidson N, et al. Phase III trial of nanoparticle albumin-bound paclitaxel compared with polyethylated castor oil-based paclitaxel in women with breast cancer. J Clin Oncol. 2005;23(31):7794-7803.